Horizon Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.8M | Sell |
173,777
-14,157
| -8% | -$377K | 0.05% | 298 |
|
|
2025
Q4 | $4.6M | Sell |
187,934
-590,163
| -76% | -$14.9M | 0.06% | 258 |
|
|
2025
Q3 | $19.5M | Buy |
778,097
+162,511
| +26% | +$4.01M | 0.26% | 72 |
|
|
2025
Q2 | $14.7M | Buy |
615,586
+529,386
| +614% | +$12.3M | 0.23% | 70 |
|
|
2025
Q1 | $2.14M | Buy |
86,200
+3,598
| +4% | +$94.2K | 0.06% | 186 |
|
|
2024
Q4 | $2.16M | Buy |
82,602
+1,271
| +2% | +$34.5K | 0.06% | 177 |
|
|
2024
Q3 | $2.32M | Buy |
81,331
+126
| +0.2% | +$3.68K | 0.06% | 153 |
|
|
2024
Q2 | $2.24M | Buy |
81,205
+1,047
| +1% | +$28.8K | 0.06% | 148 |
|
|
2024
Q1 | $2.19M | Sell |
80,158
-50,463
| -39% | -$1.4M | 0.06% | 151 |
|
|
2023
Q4 | $3.7M | Sell |
130,621
-19,555
| -13% | -$591K | 0.1% | 94 |
|
|
2023
Q3 | $4.92M | Buy |
150,176
+3,261
| +2% | +$115K | 0.15% | 71 |
|
|
2023
Q2 | $5.33M | Sell |
146,915
-3,930
| -3% | -$153K | 0.15% | 69 |
|
|
2023
Q1 | $6.09M | Sell |
150,845
-59,933
| -28% | -$2.59M | 0.18% | 61 |
|
|
2022
Q4 | $10.7M | Sell |
210,778
-77
| -0% | -$3.69K | 0.3% | 46 |
|
|
2022
Q3 | $9.15M | Buy |
210,855
+16,725
| +9% | +$813K | 0.28% | 39 |
|
|
2022
Q2 | $10.1M | Sell |
194,130
-12,415
| -6% | -$633K | 0.32% | 33 |
|
|
2022
Q1 | $10.6M | Buy |
206,545
+18,996
| +10% | +$986K | 0.3% | 42 |
|
|
2021
Q4 | $11M | Buy |
187,549
+15,988
| +9% | +$792K | 0.32% | 43 |
|
|
2021
Q3 | $7.32M | Buy |
171,561
+61,399
| +56% | +$2.72M | 0.19% | 61 |
|
|
2021
Q2 | $4.28M | Buy |
110,162
+65,225
| +145% | +$2.54M | 0.13% | 86 |
|
|
2021
Q1 | $1.63M | Buy |
+44,937
| New | +$1.6M | 0.06% | 146 |
|
|
2020
Q4 | – | Sell |
-59,720
| Closed | -$2.06M | – | 311 |
|
|
2020
Q3 | $2.06M | Sell |
59,720
-28,626
| -32% | -$1M | 0.07% | 123 |
|
|
2020
Q2 | $2.71M | Sell |
88,346
-74,960
| -46% | -$2.55M | 0.07% | 132 |
|
|
2020
Q1 | $5.01M | Sell |
163,306
-20,249
| -11% | -$690K | 0.24% | 34 |
|
|
2019
Q4 | $6.82M | Buy |
183,555
+154,211
| +526% | +$5.49M | 0.3% | 47 |
|
|
2019
Q3 | $991K | Buy |
29,344
+2,862
| +11% | +$104K | 0.04% | 115 |
|
|
2019
Q2 | $1.09M | Sell |
26,482
-63,266
| -70% | -$2.51M | 0.03% | 123 |
|
|
2019
Q1 | $3.58M | Buy |
89,748
+19,256
| +27% | +$771K | 0.13% | 62 |
|
|
2018
Q4 | $2.92M | Buy |
70,492
+14,378
| +26% | +$597K | 0.15% | 38 |
|
|
2018
Q3 | $2.33M | Buy |
56,114
+5,178
| +10% | +$199K | 0.08% | 73 |
|
|
2018
Q2 | $1.74M | Sell |
50,936
-26,378
| -34% | -$901K | 0.08% | 86 |
|
|
2018
Q1 | $2.6M | Buy |
77,314
+16,115
| +26% | +$554K | 0.11% | 55 |
|
|
2017
Q4 | $1.92M | Sell |
61,199
-11,971
| -16% | -$408K | 0.12% | 50 |
|
|
2017
Q3 | $2.29M | Buy |
73,170
+55,016
| +303% | +$1.77M | 0.13% | 51 |
|
|
2017
Q2 | $569K | Buy |
+18,154
| New | +$573K | 0.03% | 121 |
|
|
2017
Q1 | – | Sell |
-28,474
| Closed | -$877K | – | 192 |
|
|
2016
Q4 | $877K | Buy |
+28,474
| New | +$869K | 0.06% | 66 |
|
Other funds holding PFE
VCM
VPM
Horizon Investments's PFE Position: Q1 2026 in Review
Horizon Investments reduced its Pfizer (PFE) stake by 7.5% in Q1 2026, selling an estimated $377K and leaving 173,777 shares worth $4.8M. The position accounts for 0.05% of the portfolio, ranked #298.
Horizon Investments first reported a position in PFE in Q4 2016 and has held it in 36 quarters since. The position peaked at $19.5M in Q3 2025. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Horizon Investments held 173,777 shares of Pfizer worth $4.8M as of Q1 2026.
- Horizon Investments sold 14,157 Pfizer shares in Q1 2026, an estimated $377K.
- Pfizer made up 0.05% of Horizon Investments's portfolio in Q1 2026, its #298 holding.
- Horizon Investments first reported a position in Pfizer in Q4 2016 and has held it in 36 quarters since.
- Horizon Investments's Pfizer position peaked at $19.5M in Q3 2025.
- 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.